Skip to content

13F-HR filed by CAXTON CORP

CAXTON CORP filed this 13F-HR for the quarter ended 2020-06-30, filed 2020-08-14, with 15 holding rows worth $87,327,000.

Accession
0000919574-20-005228
Filed
2020-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2020

A holdings report, 15 entries on the cover page, a total value of $87,327,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $87,327,000 with VALUE read as thousands by filing date, 13F file number 028-15293. A later restatement replaced it, so the quarter does not use it. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
MOLECULAR TEMPLATES INC608550109COM2,107,991$29,069,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
STRONGBRIDGE BIOPHARMA PLCG85347105SHS USD6,612,065$24,994,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
SIERRA ONCOLOGY INC82640U404CMN643,959$7,792,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
KALA BIO INC COM483119103Stock620,289$6,519,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
SCYNEXIS INC COM NEW811292101Common Stock7,946,111$5,967,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
GARRISON CAP INC366554103COM1,164,061$3,935,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
SPDR GOLD TR78463V107GOLD SHS15,923$2,665,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
SATSUMA PHARMACEUTICALS INC80405P107COM68,172$1,961,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
MEI PHARMA INC55279B202COM NEW295,560$1,221,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
EIGER BIOPHARMACEUTICALS INC28249U105COM81,983$787,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
CTI BIOPHARMA CORP12648L601COM619,460$719,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
IVERIC BIO INC46583P102COM124,771$636,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
CARDIFF ONCOLOGY INC14147L108COM115,224$577,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
KURA ONCOLOGY INC COM50127T109Stock20,406$333,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
ADDEX THERAPEUTICS LTD00654J107SPONSORED ADS17,418$152,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000919574-20-005228this filing2020-08-14acceptance time not in the bulk data set
13F-HR/A 0000919574-20-005396 base2020-08-14acceptance time not in the bulk data set